Full text biomedical articles

Glimepiride Administered in Chow Reversibly Impairs Glucose Tolerance in Mice

Dana M. Niedowicz, Sabire Özcan, Peter T. Nelson
J Diabetes Res. 2018; 2018: 1251345. Published online 2018 Oct 29. doi: 10.1155/2018/1251345


Article   |   PubReader   |   PDF–1.8M   |   Cite

Glimepiride reduces CD14 expression and cytokine secretion from macrophages

Victoria Ingham, Alun Williams, Clive Bate
J Neuroinflammation. 2014; 11: 115. Published online 2014 Jun 21. doi: 10.1186/1742-2094-11-115


Article   |   PubReader   |   PDF–1.2M   |   Cite

Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat

Xiaojun Zhou, Rui Zhang, Zhiwei Zou, Xue Shen, Tianyue Xie, Chunmei Xu, Jianjun Dong, Lin Liao
Br J Pharmacol. 2019 Feb; 176(3): 478–490. Published online 2018 Dec 26. doi: 10.1111/bph.14553


Article   |   PubReader   |   PDF–1.3M   |   Cite

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

Alexander S. Christensen, Sofie Hædersdal, Julie Støy, Heidi Storgaard, Ulla Kampmann, Julie L. Forman, Marta Seghieri, Jens J. Holst, Torben Hansen, Filip K. Knop, Tina Vilsbøll
Diabetes Care. 2020 Sep; 43(9): 2025–2033. Published online 2020 Jul 13. doi: 10.2337/dc20-0408


Article   |   PubReader   |   PDF–964K   |   Cite

Analysis of Multi-Site Drug-Protein Interactions by High-Performance Affinity Chromatography: Binding by Glimepiride to Normal or Glycated Human Serum Albumin

Ryan Matsuda, Zhao Li, Xiwei Zheng, David S. Hage
J Chromatogr A. Author manuscript; available in PMC 2016 Aug 21.
Published in final edited form as: J Chromatogr A. 2015 Aug 21; 1408: 133–144. Published online 2015 Jul 6. doi: 10.1016/j.chroma.2015.07.012
Correction in:
volume 1423 on page 190


Article   |   PubReader   |   PDF–1.1M   |   Cite

Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride

Osama Abdelhakim Aly Ahmed, Ahmed Samir Zidan, Maan Khayat
Int J Nanomedicine. 2016; 11: 543–555. Published online 2016 Feb 3. doi: 10.2147/IJN.S99731


Article   |   PubReader   |   PDF–1.8M   |   Cite

A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures

Charmi A. Patel, Robert A. Bailey, Ujjwala Vijapurkar, Gary Meininger, Lawrence Blonde
BMC Health Serv Res. 2016; 16: 356. Published online 2016 Aug 5. doi: 10.1186/s12913-016-1607-z


Article   |   PubReader   |   PDF–728K   |   Cite

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?

Choon Ok Kim, Eun Sil Oh, Hohyun Kim, Min Soo Park
Drug Des Devel Ther. 2017; 11: 503–512. Published online 2017 Feb 23. doi: 10.2147/DDDT.S129586


Article   |   PubReader   |   PDF–575K   |   Cite

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post‐hoc analyses of a randomized, double‐blind, phase III study

Li Xin Shi, Xiao Min Liu, Yong Quan Shi, Quan Min Li, Jian Hua Ma, Yan Bing Li, Li Ying Du, Feng Wang, Lu Lu Chen
J Diabetes Investig. 2020 Jan; 11(1): 142–150. Published online 2019 Jun 13. doi: 10.1111/jdi.13075


Article   |   PubReader   |   PDF–595K   |   Cite

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East‐Asian patients with type 2 diabetes in a multicentre, double‐blind, randomized, parallel‐arm, active comparator, phase III trial

Yu Hong Chen, Chien‐Ning Huang, Young Min Cho, Pengfei Li, Liqun Gu, Feng Wang, Jun Yang, Wei Qing Wang
Diabetes Obes Metab. 2018 Sep; 20(9): 2121–2130. Published online 2018 Jun 5. doi: 10.1111/dom.13340


Article   |   PubReader   |   PDF–1.0M   |   Cite

Glimepiride Promotes Osteogenic Differentiation in Rat Osteoblasts via the PI3K/Akt/eNOS Pathway in a High Glucose Microenvironment

Pan Ma, Bin Gu, Wei Xiong, Baosheng Tan, Wei Geng, Jun Li, Hongchen Liu
PLoS One. 2014; 9(11): e112243. Published online 2014 Nov 12. doi: 10.1371/journal.pone.0112243


Article   |   PubReader   |   PDF–1.1M   |   Cite

Evaluation of Pharmacokinetic Drug Interactions Between Gemigliptin (Dipeptidylpeptidase-4 Inhibitor) and Glimepiride (Sulfonylurea) in Healthy Volunteers

Hee Youn Choi, Yo Han Kim, Mi Jo Kim, Shi Hyang Lee, Keunsu Bang, Song Han, Hyeong-Seok Lim, Kyun-Seop Bae
Drugs R D. 2014 Sep; 14(3): 165–176. Published online 2014 Jun 25. doi: 10.1007/s40268-014-0054-8


Article   |   PubReader   |   PDF–382K   |   Cite

CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide

Fayou Yang, Xiaomin Xiong, Yonghua Liu, Hong Zhang, Shibo Huang, Yuqing Xiong, Xiao Hu, Chunhua Xia
Sci Rep. 2018; 8: 10994. Published online 2018 Jul 20. doi: 10.1038/s41598-018-29351-4


Article   |   PubReader   |   PDF–1.8M   |   Cite

Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects

Vikas Kumar Dawra, David L. Cutler, Susan Zhou, Rajesh Krishna, Haihong Shi, Yali Liang, Christine Alvey, Anne Hickman, Didier Saur, Steven G. Terra, Vaishali Sahasrabudhe
Clin Pharmacol Drug Dev. 2019 Apr; 8(3): 314–325. Published online 2018 May 22. doi: 10.1002/cpdd.472


Article   |   PubReader   |   PDF–343K   |   Cite

Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects

Gehang Ju, Keyu Yan, Youwei Xu, Shilin Chen, Zhonghui Zheng, Wen Qiu
Drug Des Devel Ther. 2020; 14: 2637–2644. Published online 2020 Jul 6. doi: 10.2147/DDDT.S249355


Article   |   PubReader   |   PDF–1.3M   |   Cite

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

Rafael Simó, Bruno Guerci, Guntram Schernthaner, Baptist Gallwitz, Juan Rosas-Guzmàn, Francesco Dotta, Andreas Festa, Ming Zhou, Jacek Kiljański
Cardiovasc Diabetol. 2015; 14: 116. Published online 2015 Sep 4. doi: 10.1186/s12933-015-0279-z


Article   |   PubReader   |   PDF–994K   |   Cite

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report

Ikuko Nakamura, Jun-ichi Oyama, Hiroshi Komoda, Aya Shiraki, Yoshiko Sakamoto, Isao Taguchi, Atsushi Hiwatashi, Aiko Komatsu, Masayoshi Takeuchi, Sho-ichi Yamagishi, Teruo Inoue, Koichi Node
Cardiovasc Diabetol. 2014; 13: 15. Published online 2014 Jan 14. doi: 10.1186/1475-2840-13-15


Article   |   PubReader   |   PDF–446K   |   Cite

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride

Mikko Niemi, Kari T Kivistö, Janne T Backman, Pertti J Neuvonen
Br J Clin Pharmacol. 2000 Dec; 50(6): 591–595. doi: 10.1046/j.1365-2125.2000.00295.x


Article   |   PubReader   |   PDF–106K   |   Cite

Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination

Yu Dong, Yi-Tao Chen, Yuan-Xiao Yang, Dan Shou, Chang-Yu Li
Molecules. 2016 Nov; 21(11): 1446. Published online 2016 Oct 31. doi: 10.3390/molecules21111446


Article   |   PubReader   |   PDF–5.5M   |   Cite

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes

Dirk Müller‐Wieland, Monika Kellerer, Katarzyna Cypryk, Dasa Skripova, Katja Rohwedder, Eva Johnsson, Ricardo Garcia‐Sanchez, Raisa Kurlyandskaya, C. David Sjöström, Stephan Jacob, Jochen Seufert, Nalina Dronamraju, Katalin Csomós
Diabetes Obes Metab. 2018 Nov; 20(11): 2598–2607. Published online 2018 Jul 16. doi: 10.1111/dom.13437


Article   |   PubReader   |   PDF–793K   |   Cite